Project Grant HT94252310439
Award Date 6/1/23
Completion Date 5/31/26
Dollars Obligated $694K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14263, USA
Similar Awards
- Health Research, Inc., operating as Health Research At Roswell Park, received a $1,152,194 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research aimed at leveraging infiltrating myeloid cells to improve therapeutic response to bispecific T-cell engaging (BiTE) antibody-secreting T cells in ovarian cancer treatment. This four-year initiative...
- Health Research, Inc. Roswell Park Division received a $559,647 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research using microfluidic lung cancer models. The two-year award, made on June 1, 2023 and set to conclude on May 31, 2025, will support investigating novel drug resistance mechanisms in lung cancer through "Microfluidic Lung Cancer On A Chip" models. As a past recipient of Defense...
- Federal Project Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $929,806 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bite-secreting T cells in ovarian cancer treatment. This research...
- Federal Grant Award Summary Health Research, Inc. received a $958,389 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. As the Roswell Park Division of Health Research, the organization will conduct advanced biomedical research at its Buffalo, New York location. Based on the awardee's established portfolio, the research is expected to advance healthcare solutions...
- This Project Grant award of $695,386.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Health Research, Inc. (Roswell Park Division) to investigate translation dysregulation in metastatic breast cancer. The project aims to evaluate the implications of this phenomenon for disease outcomes and immunotherapy responses. The award period runs from March 1, 2024 to February 28, 2027. As a prime grantee,...
- The U.S. Department of Defense's Defense Health Agency awarded Health Research, Inc. a $1,545,300 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING MYCAF-DRIVEN CASTRATION-RESISTANT PROSTATE TUMOR GROWTH." The award, which has a performance period of May 1, 2024 to April 30, 2027, will enable Health Research, Inc.'s Roswell Park Division to perform biomedical research and provide scientific services to advance...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $173,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The award supports research focused on improving chemotherapy efficacy for small cell carcinomas of the bladder, a rare cancer type with significant clinical relevance to military...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park, received a $2.39M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, with a completion date of May 31, 2030. The project, titled "Stress, Lifestyle, and Immune Pathways in Aggressive Breast Cancer: An Epitranscriptomic Study," will be conducted at the organization's Buffalo, New York location....
- This $1,000,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Health Research, Inc. Inc Roswell Park Division Health Research (DBA Health Research-Roswell Park Cancer Institute Division) to target the natural immunosuppressive capabilities of endogenous beta-adrenergic neural pathways. The goal is to prolong vascularized composite allograft (VCA) graft survival and reduce toxicity risks. The...
- The Defense Health Agency awarded a $168,200 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program (CFDA 12.420) to investigate alternative polyadenylation as a mediator of therapeutic resistance in lung cancer. The two-year award beginning July 1, 2021 will support research into innovative medical solutions for lung cancer treatment through the study of alternative polyadenylation, a novel area of investigation that could help...